Marketing (Health)
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Product Launches
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Launches
Opill Launch Delivers For Perrigo While Growing Pains Slow Overall First-Quarter Results
Perrigo spares little about Opill’s launch, advertising and outlook in Q1 earnings briefing, but management also makes clear it’s a large firm and some other segments of its global consumer health products business are holding back overall results.
Bausch + Lomb’s Prescription For Consumer Health Sales Growth Includes ‘Benefit’ From Rx Drugs
Blink NutriTears supplement containing lutein/zeaxanthin, curcumin and vitamin D3 coming in 2024 is example of a cross-segment sales benefit B+L sees in dry eye product category. Consumer eye care and vision health product sales are key drivers for 18% Q1 net sales growth to $1.1bn.
OTC Marketing Awards 2024 Now Open For Entries
Returning for its 29th year, the Oscars of the OTC industry is now inviting entries from UK consumer health players across 12 categories.
Advertising Campaigns
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Ad Campaigns
OTC Marketing Awards 2024 Now Open For Entries
Returning for its 29th year, the Oscars of the OTC industry is now inviting entries from UK consumer health players across 12 categories.
Federal Judge Knows ‘Clear’ When He Reads It
The regulation “is clear, as is the Court’s order” rejecting CRN’s motion for preliminary injunction against imposition of the regulation, says US district Judge Andrew Carter in order denying the trade group’s request for clarification of New York regulation.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
Advertising Enforcement
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Ad Complaints
EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine
Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive.
Take Care With ‘Health Lite’ Claims
Some advertisers try to avoid scrutiny of regulators and the National Advertising Division when making health-related claims by making a claim “softer.” Annie Ugurlayan, NAD’s assistant director, offers advice on assuring substantiation and a health claim match.
ASA Files: How Not To Advertise A Digital Health App In The UK
ADHD-management software Happyo falls foul of UK advertising rules in a recent ASA case. The lesson: if in the UK the intended use of a digital health app is the diagnosis of a serious medical condition, supervision by a healthcare professional such as a doctor is likely to be necessary, in which case advertising to the public would also be prohibited.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.